If EU member states decide that the European Medicines Agency (EMA) should be relocated from London to Helsinki, this might open the door to a merger with the European Chemicals Agency (ECHA), which is already based in the Finnish capital.
Opportunities for "synergies" between the two agencies exist, the speakers repeated several times during a presentation of Finland's bid for EMA on Thursday (28 September).
"Of course, like all other cities, and all other countries, we have a lo...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? Login